Introduction
The study was conducted to examine the early markers for gestational diabetes mellitus (GDM) complications. The study aims to compare the relative value of antenatal criteria used for diagnosis of GDM in predicting pregnancy outcome and insulin need, by examining blood glucose threshold cut-off values from two different standards [National Diabetes Data Group criteria (NDDG) vs. Coustan and Carpenter criteria (CCC)], in a population of UAE nationals.
In 1964, O'Sullivan and Mahan suggested using glucose values in pregnant females, obtained during a 100-g, 3-h oral glucose tolerance test (OGTT), to diagnose GDM. [1] In 1979, NDDG recommended adjusting diagnostic thresholds upward. [2] Resulting values were recommended by American Diabetes Association (ADA) as diagnostic cut-off points for GDM until 1999. [3] However, in 1982, Coustan and Carpenter published a different set of interpretations of O'Sullivan and Mahan criteria. [4] In 1989, Sacks and co-workers also showed that correction of O'Sullivan's cut-offs may be necessary and suggested new cut-off values. [5] In 2000, ADA revised the recommendation for GDM diagnostic criteria and proposed adoption of CCC thresholds instead of NDDG thresholds. [6] New diagnostic criteria for diabetes mellitus outside pregnancy have been recommended by ADA [7] and World Health Organization (WHO). [8] Consensus, however, is still lacking on GDM, i.e., these bodies have not reached agreement on the criteria for GDM diagnosis, referral criteria for confi rmatory OGTT, its standardization, and diagnostic cut-off point. [9, 10] The ADA recommends selective screening for GDM in pregnant women who are at high risk, while other guidelines, including those of American College of Obstetrics and Gynecologists (ACOG), support screening of all pregnant women for GDM. [11, 12] The variation in prevalence of GDM worldwide depends on screening and diagnostic methods used as well as on age and ethnicity of the pregnant population. [13] [14] [15] [16] [17] [18] [19] The OGTT is usually performed between the 24th and 28th week of gestation; however, in women at increased risk, such as previous gestational diabetes, OGTT should be performed early after diagnosis of pregnancy. [19] It has been found that early glucose tolerance screening could avoid some diabetes-related complications in women with GDM. [20] There is controversy, for example, regarding adverse maternal and foetal outcomes when there is a single elevated 100 g OGTT value. [21] However, several studies have demonstrated that even one abnormal value is associated with unfavorable neonatal and maternal outcomes. [22] [23] [24] The ADA position statement recommends use of either the 100 g OGTT with CCC or 75 g OGTT with CCC in diagnosis of GDM. [25, 26] Some studies have also suggested that replacing NDDG criteria with the CCC would increase the number of pregnant women with a diagnosis of GDM, while only minimally affecting prevalence of infant macrosomia. [27] The fi rst population-based study of GDM prevalence, using both NDDG and CCC thresholds among a large multi-ethnic cohort, suggested that women with GDM diagnosed by CCC, who did not meet NDDG criteria, have higher rates of perinatal complications such as macrosomia, cesarean section, neonatal hypoglycemia and hyperbilirubinemia. Overall, GDM prevalence among screened women was 3.2% (95% CI 3.0-3.4) by NDDG criteria and 4.8% (95% CI 4.5-5.1) by CCC. The prevalence of GDM increased, on an average, by 50.0% with use of the CCC thresholds. [18, 28] Furthermore, the CCC better refl ect original O'Sullivan-Mahan glucose thresholds, which in turn had a (61.0%) predictive value for identifying women in whom overt diabetes would develop in the following 17-23 years and who may benefi t from diabetes prevention strategies. [29, 30] In summary, understanding the extent of GDM prevalence and associated complications is hindered by a lack of homogeneity in diagnostic criteria used in previous studies and by changes over time in recommended diagnostic glucose values.
It has been found that the number of abnormal values in 100 g diagnostic OGTT is an independent predictor of subsequent diabetes. [31, 32] Other studies found that the strongest predictive factor for progression of GDM patients to postpartum diabetes was four abnormal glucose values on diagnostic antenatal OGTT. [33] Some studies have also demonstrated that plasma glucose concentrations at each point of an OGTT postpartum are predictive for the development of type 2 diabetes. [34] Recent studies have concluded that both maternal GDM risk factors and greater carbohydrate intolerance are associated with an increase in adverse neonatal outcomes. [35, 36] The fasting glucose levels from OGTTs administered during pregnancy was the factor most often examined in studies to date. The fasting glucose level on OGTTs was found predictive for development of diabetes in the majority of studies. [37] [38] [39] [40] [41] [42] [43] [44] [45] Although 1-and 2-h plasma glucose levels were studied less often than fasting plasma glucose levels, these were also associated with future type 2 diabetes. [46] [47] [48] The area under the OGTT curve was found to be associated with type 2 diabetes in two studies. [41, 43] The commonly accepted treatment goal is to maintain a fasting capillary blood glucose level between 5.32 mmol/l and 5.88 mmol/l; the ambiguity (i.e., range) is due to imperfect data. The postprandial treatment goal should be a capillary blood glucose level of <7.8 mmol/l at 1 h and <6.7 mmol/l at 2 h. Patients not meeting these goals with dietary changes alone should begin insulin therapy. [49] A more aggressive goal of a fasting capillary blood glucose level below 95 mg/d (5.32 mmol/l) is supported by a prospective non-randomized observational study. [50, 51] This more conservative goal is recommended in the most recent ACOG practice bulletin on gestational diabetes. [13] Another prospective non-randomized study has shown a reduction in operative deliveries and birth trauma in women with GDM, who are treated with insulin. [52] Most, but not all, prospective trials involving insulin therapy in women with GDM have shown a reduction in the incidence of neonatal macrosomia. [53] [54] [55] [56] [57] [58] [59] 
Methodology
The study was a longitudinal prospective clinical trial approved by Research Ethics Committee (RECA/01/26), Faculty of Medicine, Emirates University in Al Ain, UAE. the development of some complications. Maternal and neonatal outcomes that were shown to be infl uenced by the number of abnormal values as determined by CCC or NDDG criteria were as follows.
Hydramnios (P = 0.023 and 0.096), severe hyperglycemia (P = 0.045 and 0.263), need for cesarean section (P = 0.034 and 0.471), macrosomia (P = 0.029 and 0.197) and large for gestational age (P = 0.029 and 0.063), respectively.
The number of abnormal OGTT values classifi ed under CCC had a statistically signifi cant impact on maternal and neonatal outcomes detailed above. However, on replacing by NDDG criteria, the infl uence of number of abnormal OGTT values on maternal and neonatal complications was not found to be statistically signifi cant in any case [ Table 1 ].
The infl uence of timing of abnormal OGTT values on pregnancy outcomes included odds ratios and 95.0% confi dence intervals were presented in Table 2 . No signifi cant infl uence was detected for the 1-and 2-h values. Signifi cant infl uence was, however, detected with some parameters with fasting and three hour values, [ Table 3 ].
The number of abnormal diagnostic antenatal OGTT values using CCC, significantly influenced the development of postpartum diabetes mellitus (P = 0.044) within 6 months of delivery as determined by the criteria established by Expert Committee on Diagnosis and Classifi cation of Diabetes Mellitus. [58] The association with the development of postpartum diabetes mellitus was as follows: patients with two abnormal values [n = 4; (10.5%)], with three abnormal values [n = 12; (17.6%)], and with four diagnostic OGTT abnormal values [n = 18; (30.5%)].
The chi-squared analysis of diagnostic antenatal OGTT results revealed that timing of values obtained during diagnosis of GDM (based on CCC cut-off values) was not signifi cantly related to development of postpartum diabetes mellitus. The infl uence of timing of diagnostic antenatal OGTT cut-off values (based on CCC) on insulin need during index pregnancy is presented in Table 4 . The number of abnormal OGTT values signifi cantly contributed to insulin need during index pregnancy (P < 0.05; Table 5 ).
Discussion
This study was undertaken to determine the impact on the study population of adopting CCC for GDM in place of the widely used NDDG criteria. The results demonstrated increased sensitivity of CCC when compared with NDDG criteria in diagnosis of GDM. The fi nding was consistent with that recently reported in some studies. [43, 44] The results support the current practice treated) using CCC values. A similar fi nding has been documented in a retrospective study in USA women. [26] Similar results were also demonstrated from a crosssectional study of (n = 28,330) women aimed to estimate the magnitude of change in prevalence of GDM using the CCC thresholds as compared to the NDDG thresholds. This later study documented an increased prevalence of GDM, on an average, of 50.0% from 3.2% to 4.8% with use of CCC thresholds. [18] However, prevalence of GDM diagnosis in present UAE population was found to be increased by only 12.1% using CCC as compared to NDDG criteria. This difference may be attributed in part to the small sample size used in this study as compared to two large studies mentioned above. Furthermore, study by Ferrara et al, [17] was conducted in a multiethnic 14-county region in Northern California, whereas our study was performed in a single sample of UAE nationals (i.e., in a single ethnic population). The latter is likely to be the main reason for the variation in fi ndings.
The pregnant women with a diagnosis of GDM using CCC criteria, who did not meet NDDG criteria, had high rates of macosomia. This fi nding is in agreement with that previously reported. [18, 26] However, rates of neonatal hypoglycemia and hyperbilirubinemia were not found to be increased signifi cantly as reported. [18] The number of abnormal OGTT values as determined using CCC was significantly associated with some The results indicated an association between some pregnancy complications with the timing of antenatal diagnostic threshold, particularly with fasting (≥95 mg/ dl ≡ 5.32 mmol/l) and with 3-h interval (≥140 mg/ dl ≡ 7.80 mmol/l) data. The fi nding concerning fasting glucose level has been widely reported by other researchers. [8, [36] [37] [38] 41, 42] The fi nding concerning 3-h value is of clinical importance as has not been demonstrated in any of previous studies.
An increase in number of abnormal OGTT values was associated with an increase in number of patients developing postpartum diabetes mellitus. The fi nding was similar to fi ndings reported by other researchers using different populations [30] [31] [32] and confi rms association in UAE population. However, in this later study, [32] the GDM patients were followed-up for 11 years after fi rst postpartum assessment, whereas the present study has succeeded in providing this evidence during early postpartum period.
Traditionally, insulin need in pregnancy has been determined by glycemic control during pregnancy (fasting ≥105 mg/dl and 2-h postprandial ≥120 mg/dl); however, the present study highlighted a relationship between diagnostic antenatal OGTT values and the need for insulin in GDM patients. The fasting values (≥95 mg/ dl) and 1-h values (≥180 mg/dl) were significantly associated with insulin need. Moreover, use of insulin during index pregnancy was signifi cantly infl uenced by number of abnormal OGTT values. The percentages of patients who needed insulin increased as the number of abnormal values increased. This fi nding highlights the importance of proper interpretation of diagnostic OGTT values obtained for GDM patients with regard to scheduling patients for insulin in early antenatal period before pregnancy complications ensue.
Conclusions
The CCC are superior to the NDDG criteria in the diagnosis of GDM. Use of the NDDG criteria has the potential to misdiagnose (12.1%) patients in the UAE. Such missed diagnoses have the potential to allow patients with GDM to continue with their pregnancy without proper treatment and as such increase the number of maternal and pediatric complications. The number of abnormal OGTT values obtained during the early GDM diagnosis infl uences some maternal and neonatal outcomes.
The present study identifi ed for the fi rst time, in the Al Ain, UAE population, the markers of the early development of postpartum diabetes mellitus in current GDM patients, e.g., the number of abnormal values in the 100-g diagnostic OGTT. The latter fi nding may help in screening programs for those at greater risk of developing diabetes, for whom it is imperative to set up a prevention program.
This research highlights the importance of antenatal OGTT abnormal values in identifying the need for insulin in GDM patients. The present work suggested that if abnormal values (fasting and 1-h values) are seen in the diagnostic OGTT, then insulin should be started immediately to try to prevent incidents of severe hyperglycemia at an early stage before GDM complications ensue. ) .
